318 related articles for article (PubMed ID: 26485447)
1. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
Miyazaki I; Murakami S; Torigoe N; Kitamura Y; Asanuma M
J Neurochem; 2016 Jan; 136(1):194-204. PubMed ID: 26485447
[TBL] [Abstract][Full Text] [Related]
2. Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models.
Miyazaki I; Asanuma M; Murakami S; Takeshima M; Torigoe N; Kitamura Y; Miyoshi K
Neurobiol Dis; 2013 Nov; 59():244-56. PubMed ID: 23959140
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy.
Ueda Y; Doi T; Takaki M; Nagatomo K; Nakajima A; Willmore LJ
Brain Res; 2009 Apr; 1266():1-7. PubMed ID: 19268434
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.
Isooka N; Miyazaki I; Kikuoka R; Wada K; Nakayama E; Shin K; Yamamoto D; Kitamura Y; Asanuma M
Neurochem Int; 2020 Jan; 132():104608. PubMed ID: 31765686
[TBL] [Abstract][Full Text] [Related]
5. Glutathione and Related Molecules in Parkinsonism.
Asanuma M; Miyazaki I
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445395
[TBL] [Abstract][Full Text] [Related]
6. [Anti-oxidants in astrocytes as target of neuroprotection for Parkinson's disease].
Asanuma M; Miyazaki I
Nihon Yakurigaku Zasshi; 2021; 156(1):14-20. PubMed ID: 33390474
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
Miyazaki I; Asanuma M; Kikkawa Y; Takeshima M; Murakami S; Miyoshi K; Sogawa N; Kita T
Glia; 2011 Mar; 59(3):435-51. PubMed ID: 21264950
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
Kikuoka R; Miyazaki I; Kubota N; Maeda M; Kagawa D; Moriyama M; Sato A; Murakami S; Kitamura Y; Sendo T; Asanuma M
Sci Rep; 2020 Nov; 10(1):20698. PubMed ID: 33244123
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y
FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088
[TBL] [Abstract][Full Text] [Related]
11. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.
Lewerenz J; Albrecht P; Tien ML; Henke N; Karumbayaram S; Kornblum HI; Wiedau-Pazos M; Schubert D; Maher P; Methner A
J Neurochem; 2009 Oct; 111(2):332-43. PubMed ID: 19694903
[TBL] [Abstract][Full Text] [Related]
12. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation.
Shih AY; Erb H; Sun X; Toda S; Kalivas PW; Murphy TH
J Neurosci; 2006 Oct; 26(41):10514-23. PubMed ID: 17035536
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
14. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
Bahat-Stroomza M; Gilgun-Sherki Y; Offen D; Panet H; Saada A; Krool-Galron N; Barzilai A; Atlas D; Melamed E
Eur J Neurosci; 2005 Feb; 21(3):637-46. PubMed ID: 15733082
[TBL] [Abstract][Full Text] [Related]
15. Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine.
Asanuma M; Okumura-Torigoe N; Miyazaki I; Murakami S; Kitamura Y; Sendo T
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704073
[TBL] [Abstract][Full Text] [Related]
16. The role of system Xc
Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system x
Bentea E; Van Liefferinge J; Verbruggen L; Martens K; Kobayashi S; Deneyer L; Demuyser T; Albertini G; Maes K; Sato H; Smolders I; Lewerenz J; Massie A
Exp Neurol; 2017 Apr; 290():15-28. PubMed ID: 28024798
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat.
Kobayashi S; Kuwata K; Sugimoto T; Igarashi K; Osaki M; Okada F; Fujii J; Bannai S; Sato H
Free Radic Biol Med; 2012 Dec; 53(12):2197-203. PubMed ID: 23085521
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam attenuates rotenone-induced toxicity: A rat model of Parkinson's disease.
Erbaş O; Yılmaz M; Taşkıran D
Environ Toxicol Pharmacol; 2016 Mar; 42():226-30. PubMed ID: 26896611
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
Yelkenli İH; Ulupinar E; Korkmaz OT; Şener E; Kuş G; Filiz Z; Tunçel N
J Mol Neurosci; 2016 Jun; 59(2):280-9. PubMed ID: 27115671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
